INDICATIONS AND USAGE
SPRYCEL® (dasatinib) is a prescription medicine used to treat:
- adults with newly diagnosed Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase
- adults with Ph+ CML who no longer benefit from, or did not tolerate, other treatment, including imatinib
- adults with Ph+ acute lymphoblastic leukemia (Ph+ ALL) who no longer benefit from, or did not tolerate, other treatment
- children 1 year of age and older with Ph+ CML in chronic phase
- children 1 year of age and older with newly diagnosed Ph+ ALL in combination with chemotherapy
It is not known if SPRYCEL is safe and effective in children under 1 year of age.